Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines.
Sign Up to like & getrecommendations! Published in 2019 at "Annual review of medicine"
DOI: 10.1146/annurev-med-042617-101816
Abstract: T cells are key effectors of anticancer immunity. They are capable of distinguishing tumor cells from normal ones by recognizing major histocompatibility complex-bound cancer-specific peptides. Accumulating evidence suggests that peptides associated with T cell-mediated tumor… read more here.
Keywords: tumor; individualized cancer; tumor mutations; harnessing tumor ... See more keywords